Status Epilepticus Population Study (STEPS)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Basel, Switzerland

About this trial

The aim of this observational multicenter cohort study is to gain a deeper understanding regarding the effects of treatment adaption based on information from outcome prediction models, risk stratification, as well as treatment monitoring, detection, prevention, and management of complications on course and outcome of adult patients with status epilepticus (SE).

Eligibility criteria

Qualifiers

Adult patients (i.e., patients ≥18 years of age) with diagnosed SE between 2005 and 2023 who have been treated at the University Hospital of Basel or the Cantonal Hospital Aarau.

Disqualifiers

Patients younger than 18 years.

Patients with repetitive epileptic seizures not qualifying for SE.

Patients with documented refusal of the general consent.

Trial design

Treatments tested in this trial

  • collection of patient data

Treatment groups

1,000 Participants
are divided into 1 treatment group